![Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]](/content/dam/biopharm/esperoct/global/esperoct-logo.png){kind=logo}
Your approach to treating hemophilia A can vary based on your personality. Take our 5-question quiz to discover your “treatment personality” type—and unlock insights to help you get the most out of your therapy.
Ask your doctor about a switch to Esperoct®.
Experience the Esperoct® difference–with less frequent dosing and higher factor levels compared with standard half-life products.
Esperoct® is designed to provide high factor levels and proven protection from bleeds compared with standard half-life products.
aTrough level goal is 1% for prophylaxis.
bData shown are from a study where 175 previously treated adolescents and adults received routine prophylaxis with Esperoct® 50 IU/kg every 4 days for 76 weeks. Pre-dose factor activity (trough) levels were evaluated at follow-up visits. Mean trough levels for adolescents (12-<18years) were 2.7 IU/dL.
cSteady-state factor VIII (FVIII) activity levels were estimated in 143 adults and adolescents using PK modeling.
Are you a Commander or an Investigator?
Learn more about your treatment personality type.
Are you a Commander or an Investigator?
Learn more about your treatment personality type.
Your approach to treating hemophilia A can vary based on your personality. Take our 5-question quiz to discover your “treatment personality” type—and unlock insights to help you get the most out of your therapy.
Switch to fewer infusions.
Compared with standard half-life dosing schedules, the simple, fixed dosing routine of Esperoct® calls for fewer infusions per year.
No dose adjustment needed
If you previously infused every other day
If you previously infused 3x/week
No dose adjustment needed.d
If your child previously infused every other day
If your child previously infused 3x/week
dInterval can be adjusted based on individual response to treatment.
Where can Esperoct® take you?
Even parts of Alaska reach summer temps above 90°F. Esperoct® is the only EHL product that can be stored from 86°F up to 104°F for up to 3 months. Wherever you go, Esperoct® can take the heat.
Connect with your HCL.
Questions about switching to Esperoct®? Connect with your Hemophilia Community Liaison (HCL) for personalized support in your journey with hemophilia A. Find your HCL now.
Your questions, answered.
Question: I’d like to self–infuse but have never been trained. Where can I learn how to self–infuse my factor?
Answer: Your best first stop is your healthcare provider who can answer this question as someone who understands you, your hemophilia care plan, and the facilities available in your area. You can often find infusion training at your hemophilia treatment center (HTC), specialty pharmacies, or from your physician.
Question: What is NovoCare®?
Answer: NovoCare® is a support program created to help you along your journey. NovoCare® provides assistance with coordinating insurance coverage, paying for treatment, and more. From verifying coverage to re-authorizing your prescription, we may be able to help.
eTrough level goal is 1% for prophylaxis.
fData shown are from a study where 175 previously treated adolescents and adults received routine prophylaxis with Esperoct® 50 IU/kg every 4 days for 76 weeks. Pre-dose factor activity (trough) levels were evaluated at follow-up visits. Mean trough levels for adolescents (12-<18 years) were 2.7 IU/dL.
gSteady-state factor VIII (FVIII) activity levels were estimated in 143 adults and adolescents using PK modeling.
hData shown are from 42 adults who received a pharmacokinetic (PK) assessment around the first Esperoct® 50 IU/kg dose.